Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Jun 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
59.37B | 59.38B | 54.83B | 44.57B | 40.53B | 40.20B | Gross Profit |
19.44B | 19.32B | 18.17B | 13.14B | 12.90B | 15.76B | EBIT |
3.72B | 4.02B | 3.60B | 1.77B | 1.45B | 1.67B | EBITDA |
4.50B | 5.05B | 4.51B | 3.01B | 2.76B | 2.54B | Net Income Common Stockholders |
2.16B | 2.59B | 2.21B | 1.16B | 1.01B | 1.16B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.21B | 3.57B | 6.86B | 4.51B | 3.37B | 4.26B | Total Assets |
41.96B | 39.05B | 36.40B | 29.58B | 27.09B | 26.87B | Total Debt |
5.55B | 5.61B | 822.00M | 1.25B | 1.67B | 2.32B | Net Debt |
-555.00M | 2.04B | -6.03B | -3.26B | -1.70B | -1.94B | Total Liabilities |
23.14B | 19.64B | 19.03B | 14.38B | 12.87B | 13.22B | Stockholders Equity |
18.51B | 19.07B | 17.10B | 15.05B | 14.03B | 13.53B |
Cash Flow | Free Cash Flow | ||||
0.00 | -6.92B | 3.25B | 1.93B | -915.00M | -1.76B | Operating Cash Flow |
0.00 | -150.00M | 5.61B | 2.57B | 219.00M | 3.03B | Investing Cash Flow |
0.00 | -6.76B | -2.44B | -655.00M | -643.00M | -4.57B | Financing Cash Flow |
0.00 | 3.67B | -873.00M | -798.00M | -499.00M | 1.86B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥29.15B | 8.08 | 2.12% | 3.36% | 30.33% | ||
74 Outperform | $351.15B | 16.27 | 10.34% | 2.13% | 6.45% | 4.95% | |
70 Outperform | ¥77.27B | 14.26 | 2.29% | 8.09% | 140.01% | ||
66 Neutral | ¥39.09B | 14.59 | 4.02% | 7.47% | -37.31% | ||
66 Neutral | ¥49.88B | 19.26 | 1.18% | 8.31% | 17.33% | ||
65 Neutral | $8.82B | 14.91 | 4.71% | 6.22% | 3.60% | -2.66% | |
58 Neutral | €302.36B | 54.45 | 2.04% | 1.93% | -3.24% | -63.77% |